A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

NCT03093324 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

506

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: ALKS 8700
DRUG: Dimethyl Fumarate

Sponsor

Biogen

Collaborators

[object Object]